Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations

Submitted by Frida Mäkelä on Thu, 06/08/2023 - 13:50
  • Read more about Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations

Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study

Submitted by Frida Mäkelä on Fri, 06/02/2023 - 16:27
  • Read more about Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study

The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 06/02/2023 - 16:25
  • Read more about The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study

Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 06/02/2023 - 16:23
  • Read more about Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study

Mendelian randomization indicates a causal contribution of type 2 diabetes to retinal vein occlusion

Submitted by Frida Mäkelä on Fri, 06/02/2023 - 16:21
  • Read more about Mendelian randomization indicates a causal contribution of type 2 diabetes to retinal vein occlusion

Type 2 diabetes and the risk of synovitis-tenosynovitis: a two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 05/23/2023 - 10:06
  • Read more about Type 2 diabetes and the risk of synovitis-tenosynovitis: a two-sample Mendelian randomization study

Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study

Submitted by Frida Mäkelä on Tue, 05/23/2023 - 09:54
  • Read more about Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study

Identifying potential causal effects of telomere length on health outcomes: A phenome-wide investigation and Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 05/23/2023 - 09:52
  • Read more about Identifying potential causal effects of telomere length on health outcomes: A phenome-wide investigation and Mendelian randomization study

Multiple sclerosis and breast cancer risk: a meta-analysis of observational and Mendelian randomization studies

Submitted by Frida Mäkelä on Tue, 05/23/2023 - 09:49
  • Read more about Multiple sclerosis and breast cancer risk: a meta-analysis of observational and Mendelian randomization studies

Causal effects between gut microbiota and IgA nephropathy: a bidirectional Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 05/23/2023 - 09:46
  • Read more about Causal effects between gut microbiota and IgA nephropathy: a bidirectional Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 365
  • Page 366
  • Page 367
  • Page 368
  • Current page 369
  • Page 370
  • Page 371
  • Page 372
  • Page 373
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement